Anti- Allergic

Composition – Olopatadine 0.2% w/v

        Indications – Ocular Allergic manifestation, Seasonal Allergic conjunctivitis

• Selective antagonist of histamine H1 receptors as well as a mast cell stabilizer and prevents histamine-induced inflammatory cytokine production by conjunctival epithelial cells
• Safe, well tolerated, and superior to vehicle in completely preventing ocular itching that results from allergen exposure following drug instillation in patients with allergic conjunctivitis.
• Olopatadine 0.2% was superior to epinastine 0.05% in preventing ocular itching and redness at onset when induced by the CAC (Conjunctival Allergen Challenge) model.
• Effective medication for the reduction of itching with a duration of action of up to 24 h. The added convenience of a once-a-day dosing regimen is a major advancement.
• olopatadine reduces ocular itching significantly more than ketorolac.

Exerts Dual Action-

Selective H1 receptor antagonist

Stabilizes mast cell.

Presentation- 5 ml

Composition – Olopatadine 0.1% w/v + Ketorolac Tromethamine 0.4% w/v

       Indications – Enhanced Ocular Itch, Seasonal Allergic Conjunctivitis, Ocular surface allergy and Pre and Post Operative Prophylaxis.

        Ketorolac Tromethamine

• Works by blocking the release of certain chemical messengers that cause pain and inflammation (redness and swelling) in the eye.

       Olopatadine-

• An antiallergic which blocks the action of certain chemical messengers responsible for red, itchy, watery eyes.
• The combination of 0.1% olopatadine and 0.4% ketorolac was more effective than 0.4% ketorolac alone in seasonal allergic conjunctivitis patients.

Presentation- 5 ml